IS6417A - Sýklísk fjórgild ammóníum efnasambönd - Google Patents

Sýklísk fjórgild ammóníum efnasambönd

Info

Publication number
IS6417A
IS6417A IS6417A IS6417A IS6417A IS 6417 A IS6417 A IS 6417A IS 6417 A IS6417 A IS 6417A IS 6417 A IS6417 A IS 6417A IS 6417 A IS6417 A IS 6417A
Authority
IS
Iceland
Prior art keywords
quaternary ammonium
ammonium compounds
cyclic quaternary
cyclic
compounds
Prior art date
Application number
IS6417A
Other languages
English (en)
Inventor
Siu Leung Choi Lewis
N. Beatch Gregory
P. Page Clive
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of IS6417A publication Critical patent/IS6417A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IS6417A 1999-12-15 2002-06-12 Sýklísk fjórgild ammóníum efnasambönd IS6417A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292351 1999-12-15
PCT/CA2000/001506 WO2001044192A1 (en) 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
IS6417A true IS6417A (is) 2002-06-12

Family

ID=4164887

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6417A IS6417A (is) 1999-12-15 2002-06-12 Sýklísk fjórgild ammóníum efnasambönd

Country Status (19)

Country Link
US (1) US20030166629A1 (is)
EP (1) EP1278731A1 (is)
JP (1) JP2003516966A (is)
KR (1) KR20020074170A (is)
CN (1) CN1425005A (is)
AU (1) AU2334501A (is)
BG (1) BG106816A (is)
BR (1) BR0016431A (is)
CZ (1) CZ20022095A3 (is)
EE (1) EE200200314A (is)
HU (1) HUP0301686A2 (is)
IL (1) IL150179A0 (is)
IS (1) IS6417A (is)
MX (1) MXPA02006051A (is)
NO (1) NO20022870L (is)
PL (1) PL356032A1 (is)
WO (1) WO2001044192A1 (is)
YU (1) YU44102A (is)
ZA (1) ZA200205566B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101819B1 (en) 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
CN102112121A (zh) * 2008-03-11 2011-06-29 哈佛大学校长及研究员协会 用于治疗疼痛和瘙痒的方法、组合物和药盒
CA3027255C (en) * 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2014085154A1 (en) 2012-11-27 2014-06-05 Beth Israel Deaconess Medical Center, Inc. Methods for treating renal disease
WO2015120069A1 (en) 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2020237474A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
KR20220123381A (ko) 2019-11-06 2022-09-06 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP4118070A4 (en) 2020-03-11 2024-04-10 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI58632C (fi) * 1978-02-07 1981-03-10 Orion Yhtymae Oy Foerfarande foer framstaellning av anilider med antitussiv verkan

Also Published As

Publication number Publication date
IL150179A0 (en) 2002-12-01
NO20022870D0 (no) 2002-06-14
WO2001044192A1 (en) 2001-06-21
CN1425005A (zh) 2003-06-18
AU2334501A (en) 2001-06-25
BR0016431A (pt) 2002-10-01
PL356032A1 (en) 2004-06-14
YU44102A (sh) 2005-09-19
BG106816A (en) 2003-04-30
EE200200314A (et) 2003-08-15
US20030166629A1 (en) 2003-09-04
EP1278731A1 (en) 2003-01-29
CZ20022095A3 (cs) 2003-02-12
KR20020074170A (ko) 2002-09-28
ZA200205566B (en) 2003-11-17
JP2003516966A (ja) 2003-05-20
HUP0301686A2 (hu) 2003-08-28
NO20022870L (no) 2002-08-14
MXPA02006051A (es) 2004-08-23

Similar Documents

Publication Publication Date Title
DE69905038D1 (de) Cyclische boroprolinverbindungen
DE69922494D1 (de) Zyklische n-acylamin-derivate
EE200100502A (et) Ühendid
DE60022216D1 (de) Zusammensetzung umfassend quaternäre ammoniumsalze
NO2010019I1 (no) 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE50214377D1 (de) Neuartig konfektionierte quaternäre Ammoniumverbindungen
DE50101049D1 (de) Ammoniumgruppen aufweisende organosiliciumverbindungen
IS6417A (is) Sýklísk fjórgild ammóníum efnasambönd
ID29533A (id) Senyawa-senyawa kalsilitik
DE60028852D1 (de) Fixiervorrichtung
NO20020466D0 (no) Kalsilytiske forbindelser
DE60000167D1 (de) Vibrationskreisel
NO20003024D0 (no) Innkapsling
NO20016392L (no) Antipsykotiske cykliske N-aralkylaminer
DE60110046D1 (de) Cyclische hexapeptidderivate
DE69923175D1 (de) Stabilisierte quaternäre ammoniumzusammensetzungen
AT3192U3 (de) Raumumschliessender bauteil
DE59904818D1 (de) Quartäre Ammoniumverbindungen
FI980268A0 (fi) Foerfarande foer framstaellning av cykliska monomerer
DE69925119D1 (de) Stabilisierte quaternäre ammoniumzusammensetzungen
DE50003014D1 (de) N-substituierte perhydrodiazine
DE60020323D1 (de) Schwingungsdämpfer
DK1200423T3 (da) Substituerede pehnyluraciler